Skip to main content

Table 1 Baseline characteristics of the study population by resting heart rate

From: Resting heart rate and cardiovascular outcomes in patients with non-paroxysmal atrial fibrillation: CODE-AF registry

 

Total

Resting heart rate

Maximum ASD

≤ 59 bpm

60–79 bpm

80–99 bpm

≥ 100 bpm

Before IPTW

After IPTW

Total, n

3217

286

1379

1194

358

  

Permanent AF

286 (8.9)

20 (7.0)

118 (8.6)

110 (9.2)

38 (10.6)

0.068

0.052

Age, years

70 (61–76)

69 (61–75)

69 (61–76)

70 (62–77)

70 (60–77)

0.062

0.025

Female

1087 (33.8)

84 (29.4)

485 (35.2)

386 (32.3)

132 (36.9)

0.090

0.052

Previous/current smoker

959 (29.8)

92 (32.2)

401 (29.1)

365 (30.6)

101 (28.2)

0.049

0.039

CHA2DSc-VASc

3 (2–4)

3 (1–4)

3 (2–4)

3 (2–4)

3 (2–4)

0.079

0.053

HASBLED

2 (1–2)

2 (1–2)

2 (1–3)

2 (1–2)

2 (1–3)

0.069

0.036

Comorbidity

Hypertension

476 (14.8)

187 (65.4)

973 (70.6)

830 (69.5)

251 (70.1)

0.058

0.030

Diabetes mellitus

878 (27.3)

76 (26.6)

357 (25.9)

326 (27.3)

119 (33.2)

0.084

0.048

Dyslipidemia

1029 (32.0)

90 (31.5)

453 (32.8)

373 (31.2)

113 (31.6)

0.018

0.021

Obesity

239 (7.4)

25 (8.7)

98 (7.1)

84 (7.0)

32 (8.9)

0.045

0.029

CKD

330 (10.3)

32 (11.2)

133 (9.6)

132 (11.1)

33 (9.2)

0.040

0.031

Previous MI

78 (2.4)

10 (3.5)

34 (2.5)

26 (2.2)

8 (2.2)

0.042

0.013

Previous stroke

527 (16.4)

53 (18.5)

231 (16.8)

192 (16.1)

51 (14.2)

0.061

0.042

Previous PAOD

183 (5.7)

23 (8.0)

84 (6.1)

60 (5.0)

16 (4.5)

0.082

0.035

Previous heart failure

476 (14.8)

49 (17.1)

187 (13.6)

166 (13.9)

74 (20.7)

0.110

0.026

Medication

Anti-platelet

619 (19.2)

55 (19.2)

280 (20.3)

229 (19.2)

55 (15.4)

0.065

0.039

Oral anticoagulant

2462 (76.5)

215 (75.2)

1051 (76.2)

929 (77.8)

267 (74.6)

0.042

0.027

RAS blockade

1382 (43.0)

131 (45.8)

602 (43.7)

504 (42.2)

145 (40.5)

0.058

0.044

AVN blocker

1700 (52.8)

138 (48.3)

723 (52.4)

633 (53.0)

206 (57.5)

0.095

0.066

AAD

958 (29.8)

117 (40.9)

484 (35.1)

275 (23.0)

82 (22.9)

0.241

0.050

Statin

1063 (33.0)

92 (32.2)

463 (33.6)

403 (33.8)

105 (29.3)

0.053

0.040

  1. Data are expressed as median (25th to 75th percentile) or n (%)
  2. AAD anti-arrhythmic drug, AF atrial fibrillation, ASD absolute standardized difference, AVN atrioventricular node, bpm beats per minute, CKD chronic kidney disease, IPTW inverse probability of treatment weighting, MI myocardial infarction, PAOD peripheral artery occlusive disease, RAS renin-angiotensin system